Reframing Histological Risk Assessment of Oral Squamous Cell Carcinoma in the Era of UICC 8th Edition TNM Staging.
Lymphocytic host response
Oral squamous cell carcinoma Pattern of invasion
Perineural invasion
Journal
Head and neck pathology
ISSN: 1936-0568
Titre abrégé: Head Neck Pathol
Pays: United States
ID NLM: 101304010
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
03
05
2020
accepted:
09
06
2020
pubmed:
15
7
2020
medline:
12
11
2021
entrez:
15
7
2020
Statut:
ppublish
Résumé
To assess whether application of the risk model originally proposed by Brandwein-Gensler, influences survival and disease progression in patients treated for oral squamous cell carcinoma (OSCCs) MATERIALS AND METHODS: Tumours from 134 T1 and T2 OSCC resections (7th edition) were scored independently by 3 histopathologists according to worst pattern of invasion (WPOI), lymphocytic host response (LHR) and perineural invasion (PNI) and categorised according to risk score. Local recurrence, locoregional recurrence, disease progression and overall survival were study endpoints. Interobserver variability of pathologist scoring was also assessed. Seventy-two patients (54%) were classified with low or intermediate risk and 62 (46%) patients were 'high risk'. The inter-observer agreement was in moderate to strong agreement with the consensus scores (k range = 0.45-0.82). There was statistical significance between distant metastasis and 'high risk' tumours. Thirty tumours were upstaged to T3 in the 8th edition TNM staging, of which 83% had high risk scores. Overall risk score and TNM8 T stage has significant correlation with overall survival in comparison to the TNM 7 T stage. 'High risk' tumours were significantly associated with distant metastasis possibly due to the greater likelihood of aggressive features such as WPOI and PNI. Primary tumours are more likely to express high risk features with increasing T stage. None of the patients classified as 'low risk' died perhaps suggesting these tumours represent a rare variant of OSCC with excellent prognosis.
Identifiants
pubmed: 32661668
doi: 10.1007/s12105-020-01201-8
pii: 10.1007/s12105-020-01201-8
pmc: PMC8010015
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
202-211Références
CA Cancer J Clin. 2017 Mar;67(2):122-137
pubmed: 28128848
Head Neck Pathol. 2013 Sep;7(3):211-23
pubmed: 23250819
Int J Oral Maxillofac Surg. 2014 Jul;43(7):795-801
pubmed: 24583139
J Cancer Res Clin Oncol. 2010 Jul;136(7):1039-48
pubmed: 20054559
Am J Surg Pathol. 2019 May;43(5):703-709
pubmed: 30829728
Oral Oncol. 2009 Mar;45(3):201-11
pubmed: 18674959
Histopathology. 2017 Jun;70(7):1125-1137
pubmed: 28122134
Scand J Dent Res. 1987 Jun;95(3):229-49
pubmed: 3299675
J Pathol. 1992 Apr;166(4):375-81
pubmed: 1517891
J Oral Pathol Med. 2012 Jan;41(1):34-9
pubmed: 21902722
Int J Oral Maxillofac Surg. 2015 Sep;44(9):1069-74
pubmed: 26055524
J Clin Pathol. 2019 Apr;72(4):285-294
pubmed: 30530818
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Oral Oncol. 2006 Mar;42(3):229-39
pubmed: 16150633
Am J Surg Pathol. 2005 Feb;29(2):167-78
pubmed: 15644773